CO6180436A2 - AGONIST COMPOUND AND ANTAGONISTS OF THE RECEPTOR SPHYNOSINE- 1- PHOSPHATE - Google Patents
AGONIST COMPOUND AND ANTAGONISTS OF THE RECEPTOR SPHYNOSINE- 1- PHOSPHATEInfo
- Publication number
- CO6180436A2 CO6180436A2 CO09056803A CO09056803A CO6180436A2 CO 6180436 A2 CO6180436 A2 CO 6180436A2 CO 09056803 A CO09056803 A CO 09056803A CO 09056803 A CO09056803 A CO 09056803A CO 6180436 A2 CO6180436 A2 CO 6180436A2
- Authority
- CO
- Colombia
- Prior art keywords
- substituted
- alkyl
- optionally substituted
- aryl
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/38—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Abstract
1.- Un compuesto de la Fórmula Ien donde D es H, N(R5)2 u OR6;X es CH, C(CH3) o N; Y es CH2, O, S o NR3; en donde R3 es hidrógeno, o alquil (C1-C10) recto o ramificado; A es H, hidroxi, -CH2OH, -CH(OH)CH3, -C(O)-OCH3, -C(OH)(CH3)2, -O(CH2)t-COOH, -C(O)-NR6, -(CH2)-P(=O)(OR7)(OR7) opcionalmente substituido, -(CH2)n-O-P(=O)(OR7)(OR7) opcionalmente substituido, -(CH2)n- P(=O)(OR7)(R7) opcionalmente substituido, -CH=CH-P(=O)(OR7)(OR7), C(O)-NHCH3, CN, COOR6 o -R4-COOH, en donde R4 es alquileno (C1-C20) recto o ramificado, alquenileno (C1-C20) recto o ramificado, alquinileno (C1- C20) recto o ramificado, cicloalquil (C3-C20), o azetidinil opcionalmente substituido;R1 y R2 son seleccionados, de forma independiente, a partir del grupo que consiste de hidrógeno, CF3, halógeno, alquil (C1-C20), alcoxi (C1-C20), alquil substituido con cicloalquil (C3-C20), alcoxi substituido con cicloalquil (C3-C20), alquenil (C2-C20), alquenil (C2-C20) substituido con aril, alquinil (C2- C20), alquinil (C2-C20) substituido con aril, aril, alquil (C1-C20) substituido con aril, alquil (C2-C20) substituido con heteroanil, alcoxi substituido con aril, alcoxi substituido con heteroaril, aril substituido con alquil, arilalquil, arilalquil substituido con aril, arilalquil substituido con arilalquil, CN y -O-indolizinil; en donde tales grupos R1 y R2 pueden ser opcionalmente substituidos con uno o más substituyentes seleccionados, de forma independiente, a partir de alquil (C1-C20), CF3, halógeno, hidroxi, alcoxi (C1-C20), OCF3, y CN; en donde uno o más de los átomos de carbono en los grupos R1 o R2 pueden ser independientemente reemplazados con oxígeno que no es de peróxido, azufre o NR8;en donde R8 es hidrógeno o el grupo alquil (C1-C20); en donde uno de R1 y R2 es diferente de hidrógeno; y en donde los grupos alquil, alquenil, y alquinil en R1 y R2 son opcionalmente substituidos con oxo o halógeno; cada R5 es independientemente H, alquil (C1-C3) opcionalmente substituido, o fenil opcionalmente substituido con -C(O)-O-alquil(C1-C3); cada R6 es independientemente H o alquil (C1-C2) opcionalmente substituido; ...1.- A compound of the Formula I in which D is H, N (R5) 2 or OR6, X is CH, C (CH3) or N; Y is CH2, O, S or NR3; wherein R3 is hydrogen, or straight or branched (C1-C10) alkyl; A is H, hydroxy, -CH2OH, -CH (OH) CH3, -C (O) -OCH3, -C (OH) (CH3) 2, -O (CH2) t-COOH, -C (O) -NR6 , - (CH2) -P (= O) (OR7) (OR7) optionally substituted, - (CH2) nOP (= O) (OR7) (OR7) optionally substituted, - (CH2) n- P (= O) ( OR7) (R7) optionally substituted, -CH = CH-P (= O) (OR7) (OR7), C (O) -NHCH3, CN, COOR6 or -R4-COOH, where R4 is alkylene (C1-C20) ) straight or branched, straight or branched alkenylene (C1-C20), straight or branched (C1-C20) alkynylene, cycloalkyl (C3-C20), or optionally substituted azetidinyl; R1 and R2 are independently selected from group consisting of hydrogen, CF3, halogen, (C1-C20) alkyl, (C1-C20) alkoxy, alkyl substituted with cycloalkyl (C3-C20), alkoxy substituted with cycloalkyl (C3-C20), alkenyl (C2-C20) , alkenyl (C2-C20) substituted with aryl, alkynyl (C2-C20), alkynyl (C2-C20) substituted with aryl, aryl, alkyl (C1-C20) substituted with aryl, alkyl (C2-C20) substituted with heteroanil, aryl substituted alkoxy, hete substituted alkoxy roaryl, aryl substituted with alkyl, arylalkyl, arylalkyl substituted with aryl, arylalkyl substituted with arylalkyl, CN and -O-indolizinyl; wherein such R1 and R2 groups may be optionally substituted with one or more substituents independently selected from alkyl (C1-C20), CF3, halogen, hydroxy, (C1-C20) alkoxy, OCF3, and CN; wherein one or more of the carbon atoms in the R1 or R2 groups can be independently replaced with oxygen that is not peroxide, sulfur or NR8, wherein R8 is hydrogen or the (C1-C20) alkyl group; wherein one of R1 and R2 is different from hydrogen; and wherein the alkyl, alkenyl, and alkynyl groups in R1 and R2 are optionally substituted with oxo or halogen; each R5 is independently H, optionally substituted (C1-C3) alkyl, or phenyl optionally substituted with -C (O) -O-(C1-C3) alkyl; each R6 is independently H or optionally substituted (C1-C2) alkyl; ...
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87631806P | 2006-12-21 | 2006-12-21 | |
US87628806P | 2006-12-21 | 2006-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6180436A2 true CO6180436A2 (en) | 2010-07-19 |
Family
ID=39562856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09056803A CO6180436A2 (en) | 2006-12-21 | 2009-06-02 | AGONIST COMPOUND AND ANTAGONISTS OF THE RECEPTOR SPHYNOSINE- 1- PHOSPHATE |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP2120575A4 (en) |
JP (1) | JP2010513532A (en) |
KR (1) | KR20090095659A (en) |
AR (1) | AR064650A1 (en) |
AU (1) | AU2007338700A1 (en) |
BR (1) | BRPI0720478A2 (en) |
CA (1) | CA2672727A1 (en) |
CL (1) | CL2007003784A1 (en) |
CO (1) | CO6180436A2 (en) |
CR (1) | CR10872A (en) |
DO (1) | DOP2009000149A (en) |
EC (1) | ECSP099435A (en) |
MX (1) | MX2009006751A (en) |
NO (1) | NO20092376L (en) |
PE (1) | PE20081561A1 (en) |
RU (1) | RU2009128062A (en) |
TW (1) | TW200838497A (en) |
UY (1) | UY30829A1 (en) |
WO (1) | WO2008079382A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2008134702A (en) * | 2006-01-27 | 2010-03-10 | Юниверсити Оф Вирждиния Пэтент Фаундейшн (Us) | METHOD FOR TREATING NEUROPATHIC PAIN |
CA2641718A1 (en) | 2006-02-09 | 2007-08-16 | University Of Virginia Patent Foundation | Bicyclic sphingosine 1-phosphate analogs |
JP2010510251A (en) | 2006-11-21 | 2010-04-02 | ユニバーシティ オブ バージニア パテント ファンデーション | Benzocycloheptyl analog having sphingosine = 1-phosphate receptor activity |
AU2007323540A1 (en) | 2006-11-21 | 2008-05-29 | University Of Virginia Patent Foundation | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
JP2010513531A (en) * | 2006-12-21 | 2010-04-30 | アボット・ラボラトリーズ | Process for the preparation and isolation of individual stereoisomers of 1-amino, 3-substituted phenylcyclopentanecarboxylic esters |
NZ580429A (en) | 2007-05-31 | 2012-04-27 | Sepracor Inc | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
HUE030424T2 (en) | 2008-07-23 | 2017-05-29 | Arena Pharm Inc | SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
SI2342205T1 (en) | 2008-08-27 | 2016-09-30 | Arena Pharmaceuticals, Inc. | Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
ES2590904T3 (en) | 2008-10-17 | 2016-11-24 | Akaal Pharma Pty Ltd | Modulators of S1P receptors and their use |
CA2739901A1 (en) | 2008-10-17 | 2010-04-22 | Akaal Pharma Pty Ltd | S1p receptors modulators |
AR074061A1 (en) * | 2008-10-31 | 2010-12-22 | Lexicon Pharmaceuticals Inc | S1P LIASA INHIBITORS FOR THE TREATMENT OF CEREBRAL MALARIA AND PHARMACEUTICAL FORMULATION |
AR074062A1 (en) * | 2008-10-31 | 2010-12-22 | Lexicon Pharmaceuticals Inc | S1P RECEIVER AGONISTS FOR THE TREATMENT OF BRAIN MALARIA AND PHARMACEUTICAL FORM |
WO2010085582A1 (en) | 2009-01-23 | 2010-07-29 | Bristol-Myers Squibb Company | Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
JP2012515789A (en) | 2009-01-23 | 2012-07-12 | ブリストル−マイヤーズ スクイブ カンパニー | Pyrazole-1,2,4-oxadiazole derivatives as sphingosine-1-phosphate agonists |
US8354398B2 (en) | 2009-01-23 | 2013-01-15 | Bristol-Myers Squibb Company | Substituted isoxazole compounds |
US8399451B2 (en) | 2009-08-07 | 2013-03-19 | Bristol-Myers Squibb Company | Heterocyclic compounds |
ES2937386T3 (en) | 2010-01-27 | 2023-03-28 | Arena Pharm Inc | Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts of same |
WO2011109471A1 (en) | 2010-03-03 | 2011-09-09 | Arena Pharmaceuticals, Inc. | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
EP2560969B1 (en) | 2010-04-23 | 2015-08-12 | Bristol-Myers Squibb Company | 4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-mandelic acid amides as sphingosin-1-phosphate 1 receptor agonists |
TW201643169A (en) * | 2010-07-09 | 2016-12-16 | 艾伯維股份有限公司 | Spiro-piperidine derivatives as S1P modulators |
TWI522361B (en) | 2010-07-09 | 2016-02-21 | 艾伯維公司 | Fused heterocyclic derivatives as s1p modulators |
TW201206893A (en) | 2010-07-09 | 2012-02-16 | Abbott Healthcare Products Bv | Bisaryl (thio) morpholine derivatives as S1P modulators |
ES2548258T3 (en) | 2010-09-24 | 2015-10-15 | Bristol-Myers Squibb Company | Oxadiazole compounds substituted and their use as S1P1 agonists |
JO3177B1 (en) | 2011-04-01 | 2018-03-08 | Novartis Ag | Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
UY35338A (en) * | 2013-02-21 | 2014-08-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | BICYCLIC COMPOUNDS MODULATING THE ACTIVITY OF S1P1 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO2015009731A2 (en) | 2013-07-15 | 2015-01-22 | The Regents Of The University Of California | Azacyclic constrained analogs of fty720 |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
MA40082B1 (en) * | 2014-08-20 | 2019-09-30 | Bristol Myers Squibb Co | New Sphingosine Phosphate Substitution Compound Useful Treatment Disease Rheumatism |
EP3242666A1 (en) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
JP6838744B2 (en) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (R) -2- (7- (4-cyclopentyl-3- (trifluoromethyl) benzyloxy) -1,2,3,4-tetrahydrocyclopenta [b] indole-for use in S1P1 receptor-related disorders Crystalline L-arginine salt of 3-yl) acetic acid (Compound 1) |
JP6853539B2 (en) | 2015-09-24 | 2021-03-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | Synthetic sphingolipid-like molecules, drugs, methods of synthesizing them, and methods of treatment |
CN110234633A (en) * | 2016-09-02 | 2019-09-13 | 百时美施贵宝公司 | Substituted tricyclic heterocyclic compounds |
KR20190116416A (en) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | Compounds and Methods for Treating Primary Bile Cholangitis |
CN110545848A (en) | 2017-02-16 | 2019-12-06 | 艾尼纳制药公司 | Compounds and methods for treating inflammatory bowel disease with extra-intestinal manifestations |
KR101891051B1 (en) * | 2018-01-29 | 2018-08-31 | 주식회사 세종바이오메드 | Sphingosine-1-Phosphate analogue and synthetic method thereof |
WO2020051378A1 (en) | 2018-09-06 | 2020-03-12 | Arena Pharmaceuticals, Inc. | Compounds useful in the treatment of autoimmune and inflammatory disorders |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN110808093A (en) * | 2019-09-16 | 2020-02-18 | 中山大学孙逸仙纪念医院 | Prediction model for clinical prognosis of radioactive encephalopathy and construction method thereof |
BR112022008113A2 (en) | 2019-10-31 | 2022-07-19 | Escape Bio Inc | SOLID FORMS OF A S1P RECEIVER MODULATOR |
CN117007818B (en) * | 2023-08-04 | 2024-04-09 | 徐州医科大学科技园发展有限公司 | Application of S1PR1 as target in developing or preparing medicine for preventing chronic pain related memory injury diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007111A1 (en) * | 1991-10-02 | 1993-04-15 | Smithkline Beecham Corporation | Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity |
US5314896A (en) * | 1991-11-20 | 1994-05-24 | Warner-Lambert Company | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
MX2007009848A (en) * | 2005-02-14 | 2008-03-10 | Univ Virginia | Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups. |
EP1991535A1 (en) * | 2006-02-21 | 2008-11-19 | University Of Virginia Patent Foundation | Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists |
-
2007
- 2007-12-21 TW TW096149594A patent/TW200838497A/en unknown
- 2007-12-21 UY UY30829A patent/UY30829A1/en not_active Application Discontinuation
- 2007-12-21 EP EP07863237A patent/EP2120575A4/en not_active Withdrawn
- 2007-12-21 WO PCT/US2007/026263 patent/WO2008079382A1/en active Search and Examination
- 2007-12-21 CL CL200703784A patent/CL2007003784A1/en unknown
- 2007-12-21 JP JP2009542960A patent/JP2010513532A/en not_active Withdrawn
- 2007-12-21 AR ARP070105818A patent/AR064650A1/en not_active Application Discontinuation
- 2007-12-21 AU AU2007338700A patent/AU2007338700A1/en not_active Abandoned
- 2007-12-21 KR KR1020097015385A patent/KR20090095659A/en not_active Application Discontinuation
- 2007-12-21 RU RU2009128062/04A patent/RU2009128062A/en not_active Application Discontinuation
- 2007-12-21 MX MX2009006751A patent/MX2009006751A/en not_active Application Discontinuation
- 2007-12-21 CA CA002672727A patent/CA2672727A1/en not_active Abandoned
- 2007-12-21 BR BRPI0720478-7A patent/BRPI0720478A2/en not_active Application Discontinuation
-
2008
- 2008-01-02 PE PE2008000051A patent/PE20081561A1/en not_active Application Discontinuation
-
2009
- 2009-06-02 CO CO09056803A patent/CO6180436A2/en not_active Application Discontinuation
- 2009-06-15 EC EC2009009435A patent/ECSP099435A/en unknown
- 2009-06-19 DO DO2009000149A patent/DOP2009000149A/en unknown
- 2009-06-19 CR CR10872A patent/CR10872A/en not_active Application Discontinuation
- 2009-06-22 NO NO20092376A patent/NO20092376L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2007338700A1 (en) | 2008-07-03 |
DOP2009000149A (en) | 2010-05-15 |
UY30829A1 (en) | 2008-07-31 |
CA2672727A1 (en) | 2008-07-03 |
NO20092376L (en) | 2009-06-22 |
AR064650A1 (en) | 2009-04-15 |
CL2007003784A1 (en) | 2008-06-27 |
PE20081561A1 (en) | 2008-10-30 |
BRPI0720478A2 (en) | 2014-01-14 |
JP2010513532A (en) | 2010-04-30 |
CR10872A (en) | 2009-07-23 |
MX2009006751A (en) | 2009-06-30 |
ECSP099435A (en) | 2009-07-31 |
KR20090095659A (en) | 2009-09-09 |
WO2008079382A1 (en) | 2008-07-03 |
EP2120575A1 (en) | 2009-11-25 |
TW200838497A (en) | 2008-10-01 |
EP2120575A4 (en) | 2011-04-27 |
RU2009128062A (en) | 2011-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6180436A2 (en) | AGONIST COMPOUND AND ANTAGONISTS OF THE RECEPTOR SPHYNOSINE- 1- PHOSPHATE | |
PE20110164A1 (en) | NEW PHENYLpyRAZINONES AS KINASE INHIBITORS | |
AR051734A1 (en) | REGULATION OF GROWTH OF PLANTS BY DERIVATIVES OF 2-AMINO-6-OXIPURINE. COMPOSITIONS | |
PE20141614A1 (en) | COMPOUNDS WITH ANTAGONISTIC ACTIVITY OF THE MUSCARINAL RECEPTORS AND AGONISTIC ACTIVITY OF THE BETA2 ADRENERGIC RECEPTOR | |
AR069596A1 (en) | PLANT GROWTH REGULATOR | |
AR067691A1 (en) | SULFONIMIDOIL HETEROCICLIC DERIVATIVES, PESTICIDED COMPOSITIONS THAT CONTAIN THEM AND USES OF THE SAME FOR PEST CONTROL. | |
PE20120113A1 (en) | NEW DERIVATIVES OF BENZOTIADIAZEPINES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CO6140056A2 (en) | AMINO COMPOUNDS -5-4 (DIFLUOROMETOXI) SUBSTITUTED PHENYL-5-PHENYLIMIDAZOLONE AS BETA INHIBITORS -SECRETASA | |
PE20091484A1 (en) | PYRIDINONES AND PYRIDAZINONES INHIBITING Btk | |
PE20091068A1 (en) | PIRROLO [3,2-D] PYRIMIDINE COMPOUNDS AND THEIR USE AS INHIBITORS OF KINASE PI3 AND KINASE MTOR | |
AR053149A1 (en) | USE OF DIOSMETINE COMPOUNDS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE PREVENTION AND / OR TREATMENT OF THROMBOTIC PATHOLOGIES AND PATHOLOGIES THAT CONCLUDE THE RISK OF PRODUCING THROMBOSIS | |
PE20090334A1 (en) | PIPERAZINE COMPOUNDS WITH HERBICIDAL ACTION | |
ES2525353T3 (en) | Spiroimidazolone derivative | |
CO5690578A2 (en) | ACID DERIVATIVES 4- (3- (2-PHENYLOXAZOL-4-ILMETOXI) CYCLOHEXILOXI) -BUTANOIC AND RELATED COMPOUNDS AS PPAR MODULATORS TO TREAT TYPE 2 DIABETES AND ATEROSCLEROSIS | |
EA201000017A1 (en) | PRELIMINARY COMPOSITION OF SULFUR CEMENT AND METHOD OF PREPARATION OF PRELIMINARY COMPOSITION OF SULFUR CEMENT | |
AR049555A1 (en) | DERIVATIVES OF N-PHENYLPIRAZOLS AS PESTICIDES | |
AR060379A1 (en) | COMPOUND AND HERBICIDE COMPOSITION | |
AR074020A1 (en) | FUSIONED HETEROCICLICAL COMPOUNDS AS IONIC CHANNEL MODULATORS | |
CO5690556A2 (en) | METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION | |
AR063038A1 (en) | POLICE AGENTS FOR THE TREATMENT OF INFECTION WITH RESPIRATORY SYNCTIAL VIRUSES | |
BRPI0414976A (en) | additive mixtures | |
ES2552789T3 (en) | Derivatives of 17-hydroxy-17-pentafluoroethyl-estra-4,9 (10) -dien-11-benzylidene, procedure for its preparation and use for the treatment of diseases | |
CO5690508A2 (en) | PESTICIDED MATTER COMPOSITIONS | |
PE20130694A1 (en) | COMPOSITION INCLUDING AN ACTIVE SUBSTANCE AND A POLYALKYLENOXIDE VINYLESTER GRAFTED POLYMER | |
GB2479692B (en) | Coelenteramide analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |